Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.
Diabet Med. 2009 Nov;26(11):1172-4. doi: 10.1111/j.1464-5491.2009.02855.x.
Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes mellitus characterized by an early age at onset, autosomal dominant inheritance and a primary defect in the function of the B-cells of the pancreas. We report a family with two members carrying a substitution in both the hepatocyte nuclear factor (HNF)1A and HNF4A gene simultaneously.
A 39-year-old man was referred because of mild diabetic retinopathy. Because of a dominant presentation of diabetes in his family, genetic testing was performed. Sequence analysis of the genes involved in MODY-1-3 revealed the presence of an amino acid substitution in the HNF1A as well as the HNF4A gene. Both substitutions were also detected in his mother. The HNF1A substitution has been described previously as pathogenic, whereas the HNF4A substitution had not been found previously. The HNF4A substitution was located in a conserved region of the protein and, additionally, the proband and his mother had high birthweights and low triglyceride levels, both of which are associated with pathogenic HNF4A substitutions.
To our knowledge this is the first reported family carrying both a substitution of HNF1A and HNF4A gene simultaneously. The exact contribution of each substitution to the phenotype of our subjects remains to be further elucidated, however, given the high birthweights and the low triglyceride levels in those with both substitutions, it is reasonable that the HNF4A substitution is pathogenic.
青年发病的成年型糖尿病(MODY)是一种单基因形式的糖尿病,其特征为发病年龄早、常染色体显性遗传以及胰腺β细胞功能的主要缺陷。我们报告了一个家族中的两名成员同时携带肝细胞核因子(HNF)1A 和 HNF4A 基因的替代突变。
一名 39 岁男性因轻度糖尿病视网膜病变而被转介。由于其家族中糖尿病呈显性遗传,因此进行了基因检测。MODY-1-3 相关基因的序列分析显示 HNF1A 和 HNF4A 基因均存在氨基酸替代突变。这两种替代突变也在他的母亲中被检测到。HNF1A 替代突变先前已被描述为致病性的,而 HNF4A 替代突变先前尚未发现。HNF4A 替代突变位于蛋白质的保守区域,此外,先证者及其母亲的出生体重较高且甘油三酯水平较低,这两者均与致病性 HNF4A 替代突变有关。
据我们所知,这是第一个报道同时携带 HNF1A 和 HNF4A 基因突变的家族。每个替代突变对我们研究对象表型的确切贡献仍有待进一步阐明,然而,鉴于这两种替代突变均存在高出生体重和低甘油三酯水平,HNF4A 替代突变很可能是致病性的。